Publikationen 2023
Harries, M., Jaeger, V.K., Rodiah, I., Hassenstein, M.J., Ortmann, J., Dreier, M., von Holt, I., Brinkmann, M., Dulovic, A., Gornyk, D., Hovardovska, O., Kuczewski, C., Kurosinski, M.A., Schlotz, M., Schneiderhan-Marra, N., Strengert, M., Krause, G., Sester, M., Klein, F., Petersmann, A., Karch, A., and Lange, B.
Bridging the gap - estimation of 2022/2023 SARS-CoV-2 healthcare burden in Germany based on multidimensional data from a rapid epidemic panel.
Int J Infect Dis 2023; 139:50-58. Link zum Volltext Impact Punkte: 8.4.
Mohammad, L., Fousse, M., Wenzel, G., Flotats Bastardas, M., Faßbender, K., Dillmann, U., Schick, B., Zemlin, M., Gärtner, B.C., Sester, U., Schub, D., Schmidt, T., and Sester, M.
Alterations in pathogen-specific cellular and humoral immunity associated with acute peripheral facial palsy of infectious origin.
J Neuroinflammation 2023; Link zum Volltext. Impact Punkte: 9.3.
Vasiliu, A., Martinez, L., Gupta, R.K., Hamada, Y., Ness, T., Kay, A., Bonnet, M., Sester, M., Kaufmann, S.H.E., Lange, C., and Mandalakas, A.
Tuberculosis prevention: current strategies and future directions.
Clin Microbiol Infection 2023; Link zum Artikel. Impact Punkte: 14.2.
Ziegler, L., Klemis, V., Schmidt, T., Schneitler, S., Baum, C., Neumann, J., Becker, S.L., Gärtner, B.C., Sester, U., and Sester, M.
SARS-CoV-2 specific immunity after contralateral and ipsilateral vaccination.
eBioMedicine 2023; Link zur Studie. Impact Punkte: 11.1.
Ziegler, L., Klemis, V., Schmidt, T., Schneitler, S., Baum, C., Neumann, J., Becker, S.L., Gärtner, B.C., Sester, U., and Sester, M.
Is ipsilateral administration of COVID-19 vaccine boosters the optimal approach?
eBioMedicine 2023; Link zum commentary Impact Punkte: 11.1.
Gies, S., Melchior, P., Stroeder, R., Tänzer, T., Theobald, L., Pohlers, M., Glombitza, B., Sester, M., Solomayer, E.F., and Walch-Rückheim, B.
Immune landscape of vulvar cancer patients treated with surgery and adjuvant radiotherapy revealed restricted T cell functionality and increased IL-17 expression associated with cancer relapse.
Int J Cancer 2023; in press. Link zum Volltext Impact Punkte: 6.4.
Windpessl, M., Kostopoulou, M., Conway, R., Mentese, I.B., Bruchfeld, A., Soler, M.J., Sester, M., and Kronbichler, A.
Preventing infections in immunocompromised patients with kidney diseases: Vaccines and antimicrobial prophylaxis.
Nephrol Dial Transplant 2023; Link zum Volltext. Impact Punkte: 6.1.
Bronder, S. and Sester, M.
A novel Rift Valley fever vaccine.
Lancet Infect Dis 2023 Apr 12:S1473-3099(23)00134-2; invited commentary. Impact Punkte: 56.3.
Hamada, Y., Gupta, R.K., Quartagno, M., Izzard, A., Acuna-Villaorduna, C., Altet, N., Diel, R., Dominguez, J., Floyd, S., Gupta, A., Huerga, H., Jones-Lopez, E.C., Kinikar, A., Lange, C., van Leth, F., Liu, Q., Lu, W., Lu, P., Rueda, I.L., Martinez, L., Mbandi, S.K., Munoz, L., Padilla, E.S., Paradkar, M., Scriba, T., Sester, M., Shanaube, K., Sharma, S.K., Sloot, R., Sotgiu, G., Thiruvengadam, K., Vashishtha, R., Abubakar, I., and Rangaka, M.X.
Predictive performance of interferon-gamma release assays and the tuberculin skin test for incident tuberculosis: an individual participant data meta-analysis.
EClinicalMedicine 2023; 56:101815. Impact Punkte: 15.1.
Gärtner, B.C., Klemis, V., Schmidt, T.,Sester, M., and Meyer, T.
Transient Positive SARS-CoV-2 PCR without Induction of Systemic Immune Responses.
Vaccines (Basel) 2023; 11. Impact Punkte: 7.8.
Diener, C., Hart, M., Kehl, T., Becker-Dorison, A., Tänzer, T., Schub, D., Krammes, L., Sester, M., Keller, A., Unger, M., Walch-Rückheim, B., Lenhof, H.P., and Meese, E.
Time-resolved RNA signatures of CD4+ T cells in Parkinson's disease.
Cell Death Discov 2023; 9:18. Impact Punkte: 7.0.
Karakizlis, H., Agarwal, V., Aly, M., Strecker, K., Csala, B., Esso, I., Chen, J., Nahrgang, C., Wolter, M., Slanina, H., Schuttler, C.G., Jessen, S., Ronco, C., Seeger, W., Weimer, R., Sester, M., Birk, H.W., and Husain-Syed, F.
Humoral and cellular immune responses to the mRNA-1273 SARS-CoV-2 vaccine booster in patients on maintenance dialysis.
J Nephrol 2023; 36:183-186. Impact Punkte: 3.4.
